USB U.S. Bancorp

U.S. Bank Closes $300 Million Revolving Credit Line for Adventist Health System West

U.S. Bank today announced that its Healthcare Division has acted as sole bookrunner in providing a $300 million revolving line of credit to Adventist Health System West. Adventist Health is a faith-based, not-for-profit health delivery system operating 20 hospitals and nearly 3,000 beds, as well as more than 260 clinics and other agencies.

“U.S. Bank has become the most trusted choice for many hospital systems and other healthcare providers,” said Robert Joyce, senior vice president and head of Healthcare at U.S. Bank. “We’re delighted to provide Adventist Health System West with this credit facility and look forward to continuing to support its growth and strategic mission.”

“Over the years, we have trusted in U.S. Bank’s stability and commitment to the healthcare industry,” said Brandon Seibold, treasurer at Adventist Health System West. “We appreciate that we can rely on their expertise and straightforward approach to helping us meet our complex business needs.”

U.S. Bank is a leading financial institution for organizations across the healthcare industry, including hospitals, managed care and insurers, pharmaceutical and biotech firms, and medical device companies. It counts over 75% of the top 100 not-for-profit hospital systems as clients and since 2012 has led more than 50% of syndicated transactions for not-for-profit health systems.

About U.S. Bank

Minneapolis-based U.S. Bancorp (NYSE: USB), with $450 billion in assets as of March 31, 2017, is the parent company of U.S. Bank National Association, the fifth-largest commercial bank in the United States. The company operates 3,091 banking offices in 25 states and 4,838 ATMs and provides a comprehensive line of banking, investment, mortgage, trust and payment services products to consumers, businesses and institutions. Visit U.S. Bancorp on the web at www.usbank.com.

EN
02/05/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on U.S. Bancorp

US Bancorp : 1 director

A director at US Bancorp sold/sold after exercising options 32,195 shares at 60.648USD and the significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over ...

U.S. Bancorp: Solid Q4 result with spread revenue growth

USB reported a return on average assets of 1.19%, up from 1.17% in Q3 and inside their medium term target that was set in 2024

U.S. Bancorp: U.S. Bancorp's acquisition of BTIG will round out its ca...

The strategic benefits of the transaction offset the financial impact.

U.S. Bancorp: Update to credit analysis following ratings affirmation

Our credit view of this issuer reflects its solid liquid resources, offset by its unrealized losses from interest rate marks on available-for-sale and held.

U.S. Bancorp: Key facts and statistics - Q3 September 2025

A summary company profile, detailing U.S. Bancorp’s business operations and financial highlights.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch